Professor Claude Chelala
Variant Discovery and Clinical Interpretation co-leadClaude Chelala is Professor of Bioinformatics at the Barts Cancer Institute, Queen Mary University of London. She is co-Lead of the Barts Life Sciences Precision Medicine programme aiming to link the longitudinal Electronic Health Record phenotype to multi-modal data. She leads the Health Informatics and Bioinformatics for two national biobanks harnessing longitudinal clinical, molecular and imaging data (Breast Cancer Now Tissue Bank and Pancreatic Cancer Research Fund Tissue Bank).
She leads the SNPnexus project aiming to improve our understanding of the functional role of sequence variations to prioritise clinically relevant ones. Her research in breast cancer aims to improve our understanding of ancestry-associated differences and the prognostic utility of field cancerisation. Her work on pancreatic cancer tracks tumour dynamics using liquid biopsy in unresectable patients to inform care. Now, Professor Chelala will co-lead the Variant Discovery and Clinical Interpretation community, which seeks to expedite rare disease diagnosis through genomic research.
